Moxatag

Moxatag is a brand name of amoxicillin, approved by the FDA in the following formulation(s):

MOXATAG (amoxicillin - tablet, extended release; oral)

• 
  Manufacturer: SHIONOGI INC
  
  Approval date: January 23, 2008
  
  Strength(s): 775MG ^[RLD]

Has a generic version of Moxatag been approved?

No. There is currently no therapeutically equivalent version of Moxatag available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Moxatag. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Antibiotic product, use and formulation thereof
  Patent 6,544,555
  Issued: April 8, 2003
  Inventor(s): Edward M.; Rudnic & James D.; Isbister & Donald J.; Treacy, Jr. & Sandra E.; Wassink
  Assignee(s): Advancis Pharmaceutical Corp.
  An antibiotic product is comprised of at least three dosages forms, each of which has a different release profile, with the Cmax for the antibiotic product being reached in less than about twelve hours. In one embodiment, there is an immediate release dosage form, as well as two or more delayed release dosage forms, with each of the dosage forms having a different release profile, wherein each reaches a Cmax at different times.
  
  Patent expiration dates:
  
  
  • October 13, 2020
    
    ✓ 
    Patent use: METHOD OF TREATING TONSILLITIS AND/OR PHARYNGITIS SECONDARY TO STREPTOCOCCUS PYOGENES IN A ONCE-A-DAY AMOXICILLIN PRODUCT
    ✓ 
    Drug substance
    ✓ 
    Drug product
  
  



• 
  Antibiotic product, use and formulation thereof
  Patent 6,669,948
  Issued: December 30, 2003
  Inventor(s): Edward M.; Rudnic & James D.; Isbister & Donald J.; Treacy, Jr. & Sandra E.; Wassink
  Assignee(s): Advancis Pharmaceutical Corp.
  An antibiotic product, in particular a betalactam such as cephalosporin (in particular cefuroxime and/or cefpodoxime) or a penicillin (in particular axmoxicillin or dicloxacillin) is comprised of at least three dosages forms, each of which has a different release profile, with the Cmax for the antibiotic product being reached in less than about twelve hours. In one embodiment, there is an immediate release dosage form, as well as two or more delayed release dosage forms, with each of the dosage forms having a different release profile, wherein each reaches a Cmax at different times.
  
  Patent expiration dates:
  
  
  • October 13, 2020
    
    ✓ 
    Patent use: METHOD OF TREATING TONSILLITIS AND/OR PHARYNGITIS SECONDARY TO STREPTOCOCCUS PYOGENES IN A ONCE-A-DAY AMOXICILLIN PRODUCT
    ✓ 
    Drug substance
    ✓ 
    Drug product
  
  



• 
  Antibiotic product, use and formulation thereof
  Patent 6,723,341
  Issued: April 20, 2004
  Inventor(s): Edward M.; Rudnic & James D.; Isbister & Donald J.; Treacy, Jr. & Sandra E.; Wassink
  Assignee(s): Advancis Pharmaceutical Corp.
  An antibiotic product is comprised of at least three dosages forms, each of which has a different release profile, with the Cmax for the antibiotic product being reached in less than about twelve hours. In one embodiment, there is an immediate release dosage form, as well as two or more delayed release dosage forms, with each of the dosage forms having a different release profile, wherein each reaches a Cmax at different times.
  
  Patent expiration dates:
  
  
  • October 13, 2020
    
    ✓ 
    Patent use: METHOD OF TREATING TONSILLITIS AND/OR PHARYNGITIS SECONDARY TO STREPTOCOCCUS PYOGENES IN A ONCE-A-DAY AMOXICILLIN PRODUCT
    ✓ 
    Drug substance
    ✓ 
    Drug product
  
  

See also...

• Moxatag Consumer Information (Drugs.com)
• Moxatag Extended-Release Tablets Consumer Information (Wolters Kluwer)
• Moxatag Consumer Information (Cerner Multum)
• Amoxicillin Consumer Information (Drugs.com)
• Amoxicillin Consumer Information (Wolters Kluwer)
• Amoxicillin Capsules Consumer Information (Wolters Kluwer)
• Amoxicillin Chewable Tablets Consumer Information (Wolters Kluwer)
• Amoxicillin Drops Consumer Information (Wolters Kluwer)
• Amoxicillin Extended-Release Tablets Consumer Information (Wolters Kluwer)
• Amoxicillin Suspension Consumer Information (Wolters Kluwer)
• Amoxicillin Consumer Information (Cerner Multum)
• Amoxicillin AHFS DI Monographs (ASHP)